共有 50 笔近期内部人交易记录记录，涉及 Rhythm Pharmaceuticals, Inc. (RYTM), 包括 19 笔买入 和 30 笔卖出. 内部人买入总额为 $3.32M 内部人卖出总额为 $2.23M.
近期活跃的重要内部人包括 Popovits Kimberly J, Mazabraud Yann, Mathers Edward T. 内部人交易记录可以揭示公司管理层对股票估值和未来前景的看法.
内部人交易记录 — RYTM
| 日期 |
姓名 |
职位 |
交易类型 |
股数 |
平均价格 |
总价值 |
持股数量 |
| 2026-04-01 |
Popovits Kimberly J |
Director |
未知 |
- |
- |
- |
- |
| 2026-04-01 |
Popovits Kimberly J |
Director |
限制性股票授予 (RSU) |
6,808 |
- |
- |
6,808 |
| 2026-04-01 |
Mazabraud Yann |
EVP, Head of International |
期权行权（卖出） |
2,500 |
- |
- |
5,000 |
| 2026-03-12 |
Mathers Edward T |
Director |
其他（买入） |
4,199 |
- |
- |
14,168 |
| 2026-03-04 |
German Christopher Paul |
Corporate Controller & CAO |
知情卖出 |
5,614 |
$89.56 |
$502.79K |
160 |
| 2026-03-02 |
Smith Hunter C |
Chief Financial Officer |
期权行权（卖出） |
6,099 |
$6.80 |
$41.47K |
91,401 |
| 2026-03-02 |
Mathers Edward T |
Director |
其他（买入） |
4,198 |
- |
- |
9,969 |
| 2026-03-02 |
Mazabraud Yann |
EVP, Head of International |
限制性股票授予 (RSU) |
35,000 |
$94.94 |
$3.32M |
35,000 |
| 2026-03-01 |
German Christopher Paul |
Corporate Controller & CAO |
期权行权（卖出） |
1,162 |
- |
- |
1,162 |
| 2026-02-19 |
Smith Hunter C |
Chief Financial Officer |
知情卖出 |
585 |
$103.28 |
$60.42K |
110,512 |
| 2026-02-17 |
Smith Hunter C |
Chief Financial Officer |
知情卖出 |
200 |
$103.84 |
$20.77K |
114,897 |
| 2026-02-14 |
Mazabraud Yann |
EVP, Head of International |
期权行权（卖出） |
10,000 |
- |
- |
30,000 |
| 2026-02-12 |
Smith Hunter C |
Chief Financial Officer |
知情卖出 |
100 |
$100.10 |
$10.01K |
118,466 |
| 2026-02-11 |
Smith Hunter C |
Chief Financial Officer |
限制性股票授予 (RSU) |
25,000 |
- |
- |
25,000 |
| 2026-02-11 |
German Christopher Paul |
Corporate Controller & CAO |
限制性股票授予 (RSU) |
5,215 |
- |
- |
5,215 |
| 2026-02-11 |
Meeker David P |
President and CEO |
限制性股票授予 (RSU) |
71,900 |
- |
- |
71,900 |
| 2026-02-11 |
Mazabraud Yann |
EVP, Head of International |
限制性股票授予 (RSU) |
23,350 |
- |
- |
23,350 |
| 2026-02-11 |
Lee Jennifer Kayden |
EVP, Head of North America |
限制性股票授予 (RSU) |
21,650 |
- |
- |
21,650 |
| 2026-02-11 |
Cramer Pamela J. |
Chief Human Resources Officer |
限制性股票授予 (RSU) |
11,650 |
- |
- |
11,650 |
| 2026-02-11 |
Shulman Joseph |
Chief Technical Officer |
限制性股票授予 (RSU) |
15,000 |
- |
- |
15,000 |
| 2026-02-11 |
Garfield Alastair |
Chief Scientific Officer |
限制性股票授予 (RSU) |
16,650 |
- |
- |
16,650 |
| 2026-02-10 |
Smith Hunter C |
Chief Financial Officer |
知情卖出 |
100 |
$104.76 |
$10.48K |
122,824 |
| 2026-02-05 |
Smith Hunter C |
Chief Financial Officer |
知情卖出 |
3,381 |
$106.06 |
$358.6K |
125,537 |
| 2026-02-04 |
Smith Hunter C |
Chief Financial Officer |
知情卖出 |
747 |
$107.67 |
$80.43K |
128,918 |
| 2026-02-01 |
German Christopher Paul |
Corporate Controller & CAO |
RSU 预扣税 |
1,138 |
$108.99 |
$124.03K |
3,433 |
| 2026-02-01 |
Meeker David P |
President and CEO |
期权行权（卖出） |
14,125 |
- |
- |
14,125 |
| 2026-02-01 |
Smith Hunter C |
Chief Financial Officer |
期权行权（卖出） |
4,062 |
- |
- |
- |
| 2026-02-01 |
Mazabraud Yann |
EVP, Head of International |
期权行权（卖出） |
5,500 |
- |
- |
11,000 |
| 2026-02-01 |
Lee Jennifer Kayden |
EVP, Head of North America |
期权行权（卖出） |
3,437 |
- |
- |
- |
| 2026-02-01 |
Cramer Pamela J. |
Chief Human Resources Officer |
期权行权（卖出） |
2,343 |
- |
- |
- |
| 2026-02-01 |
Shulman Joseph |
Chief Technical Officer |
期权行权（卖出） |
2,656 |
- |
- |
- |
| 2026-02-01 |
Garfield Alastair |
Chief Scientific Officer |
RSU 预扣税 |
2,026 |
$108.99 |
$220.81K |
7,763 |
| 2025-12-11 |
Cramer Pamela J. |
Chief Human Resources Officer |
期权行权（卖出） |
3,350 |
$27.35 |
$91.62K |
8,375 |
| 2025-11-20 |
Cramer Pamela J. |
Chief Human Resources Officer |
期权行权（卖出） |
3,350 |
$27.35 |
$91.62K |
11,725 |
| 2025-06-24 |
Mcgirr David W J |
Director |
限制性股票授予 (RSU) |
4,712 |
- |
- |
4,712 |
| 2025-06-24 |
Good Jennifer L |
Director |
限制性股票授予 (RSU) |
4,712 |
- |
- |
4,712 |
| 2025-06-24 |
Bedrosian Camille L |
Director |
限制性股票授予 (RSU) |
4,712 |
- |
- |
4,712 |
| 2025-06-24 |
Mathers Edward T |
Director |
限制性股票授予 (RSU) |
4,712 |
- |
- |
4,712 |
| 2025-06-24 |
Jean Christophe |
Director |
限制性股票授予 (RSU) |
4,712 |
- |
- |
4,712 |
| 2025-06-24 |
Arbuckle Stuart A |
Director |
限制性股票授予 (RSU) |
4,712 |
- |
- |
4,712 |
| 2025-06-24 |
Tetrault Lynn A. |
Director |
限制性股票授予 (RSU) |
4,712 |
- |
- |
4,712 |
| 2025-06-18 |
Mcgirr David W J |
Director |
期权行权（卖出） |
4,000 |
- |
- |
- |
| 2025-06-18 |
Good Jennifer L |
Director |
期权行权（卖出） |
4,000 |
- |
- |
- |
| 2025-06-18 |
Bedrosian Camille L |
Director |
期权行权（卖出） |
4,000 |
- |
- |
- |
| 2025-06-18 |
Mathers Edward T |
Director |
期权行权（卖出） |
4,000 |
- |
- |
- |
| 2025-06-18 |
Jean Christophe |
Director |
期权行权（卖出） |
4,000 |
- |
- |
- |
| 2025-06-18 |
Arbuckle Stuart A |
Director |
期权行权（卖出） |
4,000 |
- |
- |
- |
| 2025-06-18 |
Tetrault Lynn A. |
Director |
期权行权（卖出） |
4,000 |
- |
- |
- |
| 2025-06-10 |
German Christopher Paul |
Corporate Controller & CAO |
知情卖出 |
2,069 |
$67.19 |
$139.02K |
1,889 |
| 2025-06-06 |
Cramer Pamela J. |
Chief Human Resources Officer |
知情卖出 |
7,031 |
$68.05 |
$478.43K |
19,209 |
■ 知情交易 — 公开市场买卖（最具参考价值）
■ 非知情买入 — 奖励、期权行权、转换
■ 非知情卖出 — 税务代扣、归属出售
■ 中性 — 礼赠、信托、到期
